Investor Lists

Biotech investors based in New York

Updated 7 November 2026

Firms with an address in New York that we have watched back a biotech company in the last two years.

See all 83 →The top 25
83investors on the list+2 this week
1,511cheques in 12 months-6% against the market
$25Mmedian round they joined+213% against the market median
94%wrote a cheque in 12 months
61%have led a round

The Top 25

Ordered by cheques observed, never by anything anyone paid for

Deploying now (25)

  1. 1SOSVDeploying nowVC firm · United States951$2.5Mmedian roundNov 2026last seen
  2. 2BoxGroupDeploying nowVC firm · United States773$18Mmedian roundNov 2026last seen
  3. 3Tiger Global ManagementDeploying nowVC firm · United States773$47Mmedian roundNov 2026last seen
  4. 4Insight PartnersDeploying nowVC firm · United States765$40Mmedian roundOct 2026last seen
  5. 5FlybridgeDeploying nowVC firm · United States534$5Mmedian roundSept 2026last seen
  6. 6OrbiMedDeploying nowPrivate equity · United States447$71Mmedian roundOct 2026last seen
  7. 7Lux CapitalDeploying nowVC firm · United States445$30Mmedian roundNov 2026last seen
  8. 8Lerer HippeauDeploying nowVC firm · United States419$9.7Mmedian roundNov 2026last seen
  9. 9Union Square VenturesDeploying nowVC firm · United States407$17Mmedian roundNov 2026last seen
  10. 10CoatueDeploying nowVC firm · United States404$85Mmedian roundOct 2026last seen
  11. 11Great Oaks Venture CapitalDeploying nowVC firm · United States369$5Mmedian roundSept 2026last seen
  12. 12Collaborative FundDeploying nowVC firm · United States305$7.5Mmedian roundOct 2026last seen
  13. 13General AtlanticDeploying nowPrivate equity · United States273$127Mmedian roundOct 2026last seen
  14. 14Warburg PincusDeploying nowPrivate equity · United States260$124Mmedian roundOct 2026last seen
  15. 15Pareto HoldingsDeploying nowVC firm · United States239$3.3Mmedian roundOct 2026last seen
  16. 16Perceptive AdvisorsDeploying nowAsset manager · United States206$100Mmedian roundOct 2026last seen
  17. 17DeerfieldDeploying nowVC firm · United States198$50Mmedian roundOct 2026last seen
  18. 18New York AngelsDeploying nowAngel network · United States181$2.1Mmedian roundSept 2026last seen
  19. 19InvusDeploying nowPrivate equity · United States148$81Mmedian roundOct 2026last seen
  20. 20Point72 VenturesDeploying nowVC firm · United States148$15Mmedian roundNov 2026last seen
  21. 21Lowercarbon CapitalDeploying nowVC firm · United States146$21Mmedian roundOct 2026last seen
  22. 22White Star CapitalDeploying nowVC firm · United States142$12Mmedian roundSept 2026last seen
  23. 23Two Sigma VenturesDeploying nowVC firm · United States123$22Mmedian roundSept 2026last seen
  24. 24AlleyCorpDeploying nowVenture studio · United States122$10Mmedian roundSept 2026last seen
  25. 25ApolloDeploying nowPrivate equity · United States114$55Mmedian roundOct 2026last seen
58 more on this list

All 83 are in the app, with filters for stage, sector and market. A free account shows 10 per search, Pro up to 1,000.

See the whole list →

Quick answers about biotech investors based in New York

Who are the most active biotech investors based in New York?

By cheques observed, the most active are SOSV, BoxGroup, Tiger Global Management, Insight Partners and Flybridge.

How many biotech investors based in New York are there?

83 are on record. 94% made an investment in the last 12 months and 61% have led a round.

Which stages do biotech investors based in New York back?

Of the rounds with a named stage in the last 12 months, mostly Series A (22%) and Seed (21%).

How big are the rounds biotech investors based in New York join?

The typical (median) round among the leading investors here is $21M.

Which sectors do biotech investors based in New York back most?

In the last 12 months, mostly AI, Biotech and Healthcare.

Which biotech investors based in New York lead the most rounds?

Insight Partners (43 led), Tiger Global Management (42 led) and General Atlantic (32 led).

What have biotech investors based in New York invested in recently?

Recent rounds include Harbinger (Series D+, Nov 2026, with Tiger Global Management), T-Therapeutics (Series B, Nov 2026, with Digitalis Ventures) and Potential Sciences (Seed, Nov 2026, with Odyssey).

How is this list of biotech investors based in New York ranked?

By cheques observed, from the rounds and filings we watched, and never by anything anyone paid for. It is rebuilt every night.

Built from the rounds we watched, refreshed every night. How we count · Report a correction